journal article·2023-01-04Open access

Increased UHMWPE Particle-Induced Osteolysis in Fetuin-A-Deficient Mice

Christina Polan, Christina Brenner, Monika Herten, Gero Hilken, Florian Grabellus, Heinz-Lothar Meyer, Manuel Burggraf, Marcel Dudda, Willi Jahnen-Dechent, Christian Wedemeyer, Max Daniel Kauther

Abstract

Particle-induced osteolysis is a major cause of aseptic prosthetic loosening. Implant wear particles stimulate tissue macrophages inducing an aseptic inflammatory reaction, which ultimately results in bone loss. Fetuin-A is a key regulator of calcified matrix metabolism and an acute phase protein. We studied the influence of fetuin-A on particle-induced osteolysis in an established mouse model using fetuin-A-deficient mice. Ten fetuin-A-deficient (Ahsg−/−) mice and ten wild-type animals (Ahsg+/+) were assigned to test group receiving ultra-high molecular weight polyethylene (UHMWPE) particle implantation or to control group (sham surgery). After 14 days, bone metabolism parameters RANKL, osteoprotegerin (OPG), osteocalcin (OC), alkaline phosphatase (ALP), calcium, phosphate, and desoxypyridinoline (DPD) were examined. Bone volume was determined by microcomputed tomography (μCT); osteolytic regions and osteoclasts were histomorphometrically analyzed. After particle treatment, bone resorption was significantly increased in Ahsg−/− mice compared with corresponding Ahsg+/+ wild-type mice (p = 0.007). Eroded surface areas in Ahsg−/− mice were significantly increased (p = 0.002) compared with Ahsg+/+ mice, as well as the number of osteoclasts compared with control (p = 0.039). Fetuin-A deficiency revealed increased OPG (p = 0.002), and decreased levels of DPD (p = 0.038), OC (p = 0.036), ALP (p < 0.001), and Ca (p = 0.001) compared with wild-type animals. Under osteolytic conditions in Ahsg−/− mice, OPG was increased (p = 0.013), ALP (p = 0.015) and DPD (p = 0.012) were decreased compared with the Ahsg+/+ group. Osteolytic conditions lead to greater bone loss in fetuin-A-deficient mice compared with wild-type mice. Reduced fetuin-A serum levels may be a risk factor for particle-induced osteolysis while the protective effect of fetuin-A might be a future pathway for prophylaxis and treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Orthopaedic implants and arthroplasty · Bone Tissue Engineering Materials · Bone and Joint Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Trauma, Hand and Reconstructive Surgery, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany

Central Animal Laboratory, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany

Institute of Pathology and Neuropathology, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany

Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University Hospital, 52074 Aachen, Germany

Department of Orthopaedic Surgery, St. Barbara Hospital Gladbeck, 45964 Gladbeck, Germany

Department of Trauma Surgery and Orthopedics, Pediatric Orthopedics, Agaplesion Diakonieklinikum Rotenburg (Wümme), 27356 Rotenburg, Germany

Funding

Deutsche Forschungsgemeinschaft · Open Access Publication Fund of the University of Duisburg-Essen, Germany · IFORES grant from the University Hospital Essen, Germany

References (47)

Show source-provided references
1. Revision surgery after total joint arthroplasty: A complication-based analysis using worldwide arthroplasty registers10.1016/j.arth.2013.01.012 ↗
2. Particle disease: Biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty10.1177/1753425912451779 ↗
3. Goodman, S.B., and Gallo, J. (2019). Periprosthetic Osteolysis: Mechanisms, Prevention and Treatment. J. Clin. Med., 8.10.3390/jcm8122091 ↗
4. The size and shape of particulate polyethylene wear debris in total joint replacements10.1243/0954411971534638 ↗
5. Evaluation of the response of primary human peripheral blood mononuclear phagocytes to challenge with in vitro generated clinically relevant UHMWPE particles of known size and dose10.1002/1097-4636(200011)52:2<296::AID-JBM8>3.0.CO;2-9 ↗
6. The cell biology of bone metabolism10.1136/jcp.2007.048868 ↗
7. Mechanisms of disease: Molecular insights into aseptic loosening of orthopedic implants10.1038/ncprheum0428 ↗
8. The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses10.1098/rsif.2008.0142 ↗
9. Minireview: The OPG/RANKL/RANK system10.1210/endo.142.12.8536 ↗
10. Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: Maintaining the balance to prevent bone loss
11. Biological reactions to wear debris in total joint replacement10.1243/0954411001535219 ↗
12. Activation of NF-kappaB signalling and TNFalpha-expression in THP-1 macrophages by TiAlV- and polyethylene-wear particles
13. IL-1 mediates TNF-induced osteoclastogenesis10.1172/JCI200523394 ↗
14. Localisation of plasma alpha2HS glycoprotein in mineralising human bone10.1038/256430a0 ↗
15. Origin of plasma alpha2HS-glycoprotein and its accumulation in bone10.1038/262226a0 ↗
16. The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification10.1172/JCI17202 ↗
17. Fetuin-A regulation of calcified matrix metabolism10.1161/CIRCRESAHA.110.234260 ↗
18. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis10.1074/jbc.271.34.20789 ↗
19. Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles10.1074/jbc.M709938200 ↗
20. Fetuin-A is a HIF target that safeguards tissue integrity during hypoxic stress10.1038/s41467-020-20832-7 ↗
21. Clinical implications of fetuin-A10.1016/bs.acc.2018.12.003 ↗
22. Anti-inflammatory role of fetuin-A in injury and infection10.2174/156652412800620039 ↗
23. Modification of macrophage response to lipopolysaccharide by fetuin10.1016/S0165-2478(97)00126-0 ↗
24. Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan10.1097/00024382-200115030-00004 ↗
25. Role of fetuin A in the diagnosis and treatment of joint arthritis10.5312/wjo.v8.i6.461 ↗
26. A single intraperitoneal injection of bovine fetuin-A attenuates bone resorption in a murine calvarial model of particle-induced osteolysis10.1016/j.bone.2017.09.006 ↗
27. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis10.1016/S0002-9440(10)65266-2 ↗
28. Polyethylene particle-induced bone resorption in alpha-calcitonin gene-related peptide-deficient mice10.1359/jbmr.070408 ↗
29. Cloning and targeted deletion of the mouse fetuin gene10.1074/jbc.272.50.31496 ↗
30. Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice10.1093/ndt/gfm094 ↗
31. Stimulation of bone formation by zoledronic acid in particle-induced osteolysis10.1016/j.biomaterials.2004.09.026 ↗
32. Kauther, M.D., Bachmann, H.S., Neuerburg, L., Broecker-Preuss, M., Hilken, G., Grabellus, F., Koehler, G., von Knoch, M., and Wedemeyer, C. (2011). Calcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis. BMC Musculoskelet Disord, 12.10.1186/1471-2474-12-186 ↗
33. Bone histomorphometry: Proposed system for standardization of nomenclature, symbols, and units10.1007/BF02556360 ↗
34. Fetuin protects the fetus from TNF10.1016/S0140-6736(05)62030-2 ↗
35. Li, W., Zhu, S., Li, J.H., Huang, Y., Zhou, R.R., Fan, X.G., Yang, H.A., Gong, X., Eissa, N.T., and Jahnen-Dechent, W. (2011). A Hepatic Protein, Fetuin-A, Occupies a Protective Role in Lethal Systemic Inflammation. PLoS ONE, 6.10.1371/journal.pone.0016945 ↗
36. Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity10.3389/fimmu.2018.01991 ↗
37. Live Imaging of Calciprotein Particle Clearance and Receptor Mediated Uptake: Role of Calciprotein Monomers10.3389/fcell.2021.633925 ↗
38. Over-expression of p53/BAK in aseptic loosening after total hip replacement10.1016/j.biomaterials.2006.01.006 ↗
39. Extrinsic and intrinsic pathways of apoptosis in aseptic loosening after total hip replacement10.1016/j.biomaterials.2008.04.044 ↗
40. Fetuin/alpha(2)-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages10.1042/CS20030126 ↗
41. Brylka, L.J., Köppert, S., Babler, A., Kratz, B., Denecke, B., Yorgan, T.A., Etich, J., Costa, I.G., Brachvogel, B., and Boor, P. (2017). Post-weaning epiphysiolysis causes distal femur dysplasia and foreshortened hindlimbs in fetuin-A-deficient mice. PLoS ONE, 12.10.1371/journal.pone.0187030 ↗
42. Seto, J., Busse, B., Gupta, H.S., Schäfer, C., Krauss, S., Dunlop, J.W.C., Masic, A., Kerschnitzki, M., Zaslansky, P., and Boesecke, P. (2012). Accelerated Growth Plate Mineralization and Foreshortened Proximal Limb Bones in Fetuin-A Knockout Mice. PLoS ONE, 7.10.1371/journal.pone.0047338 ↗
43. Association of Fetuin-A With Incident Fractures in Community-Dwelling Older Adults: The Cardiovascular Health Study10.1002/jbmr.2475 ↗
44. Evaluation of fetuin-A as a predictor of outcome after surgery for osteoporotic fracture of the proximal femur10.1007/s00402-019-03329-x ↗
45. Babler, A., Schmitz, C., Buescher, A., Herrmann, M., Gremse, F., Gorgels, T., Floege, J., and Jahnen-Dechent, W. (2020). Microvasculopathy and soft tissue calcification in mice are governed by fetuin-A, magnesium and pyrophosphate. PLoS ONE, 15.10.1371/journal.pone.0228938 ↗
46. Herrmann, M., Babler, A., Moshkova, I., Gremse, F., Kiessling, F., Kusebauch, U., Nelea, V., Kramann, R., Moritz, R.L., and McKee, M.D. (2020). Lumenal calcification and microvasculopathy in fetuin-A-deficient mice lead to multiple organ morbidity. PLoS ONE, 15.10.1371/journal.pone.0228503 ↗
47. New animal models of wear-particle osteolysis10.1007/s00264-010-1143-0 ↗